Amy P. Sing

Nessuna posizione attualmente

65 anni

Health Technology

Consumer Services

Profilo

Amy P.
Sing worked as a Senior Director-Medical Affairs at Seagen Inc. from 1999 to 2003.
She also worked as a Senior Director-Medical Affairs at Genomic Health, Inc. She served as an Independent Director at Bio-Path Holdings, Inc. from 2014 to 2017.
Dr. Sing holds a doctorate degree from Stanford University and an undergraduate degree from Amherst College.

Precedenti posizioni note di Amy P. Sing

Società	Posizione	Fine
BIO-PATH HOLDINGS, INC.	Direttore/Membro del Consiglio	10/08/2017
GENOMIC HEALTH, INC.	Direttore Tecnico/Scientifico/R&S	-
SEAGEN INC.	Direttore Tecnico/Scientifico/R&S	01/01/2003

Vedi nel dettaglio l'esperienza di Amy P. Sing

Formazione di Amy P. Sing

Amherst College	Undergraduate Degree
Stanford University	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Amy P. Sing

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
BIO-PATH HOLDINGS, INC.	Health Technology

Aziende private	2
Seagen Inc. Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.	Health Technology
Genomic Health, Inc. Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA.	Health Technology